SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Director/PDMR Shareholding

20 Mar 2009 14:40

RNS Number : 2289P
Rentokil Initial PLC
20 March 2009
 



NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R(1).

 

(1)

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2)

An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24. 

(3)

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24. 

(4)

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. 

 

Please complete all relevant boxes in block capital letters.

1. Name of the issuer

RENTOKIL INITIAL PLC

2. State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.4R(1)(a); or

(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or 

(iii) both (i) and (ii)

BOTH (i) and (ii)

3. Name of person discharging managerial responsibilities/director

JOHN MCADAM

ALAN BROWN

ANDY RANSOM

MICHAEL MURRAY

4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

N/A

5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

BENEFICIAL HOLDING OF PERSONS NAMED IN 3. above

6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares

 ORDINARY SHARES OF 1 PENCE EACH

7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

JOHN MCADAM - NIL ORDINARY SHARES

ALAN BROWN - NIL ORDINARY SHARES

ANDY RANSOM - NIL ORDINARY SHARES

MICHAEL MURRAY - NIL ORDINARY SHARES

8 State the nature of the transaction

a) ACQUISTION OF SHARES BY JOHN MCADAM, ALAN BROWN, ANDY RANSOM AND MICHAEL MURRAY

b) AWARD UNDER THE RENTOKIL INITIAL PERFORMANCE SHARE PLAN FOR MICHAEL MURRAY

9. Number of shares, debentures or financial instruments relating to shares acquired

JOHN MCADAM - 20,800 ORDINARY SHARES OF 1P EACH

ALAN BROWN - 20,800 ORDINARY SHARES OF 1P EACH

ANDY RANSOM- 52,000 ORDINARY SHARES OF 1P EACH

MICHAEL MURRAY - 52,000 ORDINARY SHARES OF 1P EACH

10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

JOHN MCADAM- 0.00115%

ALAN BROWN - 0.00115%

ANDY RANSOM - 0.00286%

MICHAEL MURRAY- 0.00286%

11. Number of shares, debentures or financial instruments relating to shares disposed

NIL

12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) 

NIL

13. Price per share or value of transaction

BOUGHT TOTAL 145,600 ORDINARY SHARES AT 48.0969p per share

14. Date and place of transaction

19 MARCH 2009LONDON

15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

JOHN MCADAM - 20,800 ORDINARY SHARES OF 1P EACH - 0.00115%

ALAN BROWN - 20,800 ORDINARY SHARES OF 1P EACH - 0.00115%

ANDY RANSOM- 52,00ORDINARY SHARES OF 1P EACH - 0.00286%

MICHAEL MURRAY - 52,000 ORDINARY SHARES OF 1P EACH - 0.00286%

16. Date issuer informed of transaction

19 MARCH 2009

If a director/person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

17 Date of grant

19 MARCH 2009

18. Period during which or date on which it can be exercised

26 JUNE 2011 TO 25 JUNE 2018 (subject to performance conditions)

19. Total amount paid (if any) for grant of the option

NIL

20. Description of shares or debentures involved (class and number)

ORDINARY SHARES OF 1 PENCE EACH 

MICHAEL MURRAY - 1,200,000 PERFORMANCE SHARE PLAN AWARDS (600,000 FOR TARGET PERFORMANCE)

SUBJECT TO THE PERFORMANCE CONDITIONS OF THE 2008 PLAN.

21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

NIL

22. Total number of shares or debentures over which options held following notification

MICHAEL MURRAY - 1,200,000 PERFORMANCE SHARE PLAN AWARDS

23. Any additional information

N/A

24. Name of contact and telephone number for queries

PAUL GRIFFITHS- 020 7592 2700

Name and signature of duly authorised officer of issuer responsible for making notification

PAUL GRIFFITHS

Date of notification

20 MARCH 2009

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBSGDXCXDGGCG
Date   Source Headline
21st May 20267:00 amRNSAppointment of CEO, North America
8th May 202610:30 amRNSHolding(s) in Company
7th May 20264:40 pmRNSResult of AGM
23rd Apr 20264:25 pmRNSFinal Dividend – Pence Sterling Amount Payable
23rd Apr 20262:30 pmRNSIssuance of $500 million 4.625% Notes due 2031
21st Apr 202610:30 amRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ1 Trading Update
15th Apr 20267:00 amRNSDirectorate Change
30th Mar 202610:30 amRNSHolding(s) in Company
26th Mar 20263:46 pmRNSDirector/PDMR Shareholding
25th Mar 202610:50 amRNSAnnual Financial Report
17th Mar 20264:30 pmRNSDirector/PDMR Shareholding
16th Mar 202610:32 amRNSHolding(s) in Company
16th Mar 202610:32 amRNSHolding(s) in Company
12th Mar 202610:30 amRNSHolding(s) in Company
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
9th Mar 202611:15 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSPreliminary Results
5th Mar 20267:00 amRNSChair Succession Planning Update
23rd Feb 202610:30 amRNSHolding(s) in Company
19th Feb 20262:50 pmRNSDirector Declaration
12th Feb 20265:30 pmRNSNotice of Early Redemption
20th Jan 202610:25 amRNSHolding(s) in Company
19th Jan 202610:30 amRNSHolding(s) in Company
16th Jan 20263:00 pmRNSHolding(s) in Company
14th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 20267:00 amRNSDirectorate change
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
5th Dec 202510:30 amRNSHolding(s) in Company
5th Dec 202510:30 amRNSHolding(s) in Company
26th Nov 20254:25 pmRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
27th Oct 202510:30 amRNSHolding(s) in Company
23rd Oct 202511:45 amRNSHolding(s) in Company
23rd Oct 20257:00 amRNSQ3 Trading Update
21st Oct 202510:00 amRNSHolding(s) in Company
14th Oct 202510:00 amRNSHolding(s) in Company
1st Oct 202510:30 amRNSBlock listing Interim Review
30th Sep 202510:30 amRNSCompletion of France Workwear business sale
25th Sep 20254:15 pmRNSDirector/PDMR Shareholding
24th Sep 20256:00 pmRNSDirector Declaration
26th Aug 202512:30 pmRNSInterim Dividend – Pence Sterling Amount Payable
7th Aug 202511:10 amRNSHolding(s) in Company
31st Jul 20257:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.